Cimeio Therapeutics
  • Home
  • About Us
  • Publications
  • News
  • Contact Us
  • Careers
Select Page

Selective haematological cancer eradication with preserved haematopoiesis

by admin | May 22, 2024 | Publication

Selective haematological cancer eradication with preserved haematopoiesis Simon Garaudé1,2,15,Romina Marone1,2,15, Rosalba Lepore1,2,3, Anna Devaux1,2, Astrid Beerlage1,2,4, Denis Seyres1,2, Alessandro Dell’ Aglio1,2, Darius Juskevicius5, Jessica Zuin1,2, Thomas...

Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy

by admin | Sep 29, 2023 | Publication

Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy Romina Marone1,2, Emmanuelle Landmann1,2, Anna Devaux1,2, Rosalba Lepore1,2,3,4, Denis Seyres1,2, Jessica Zuin1,2, Thomas Burgold1,2, Corinne Engdahl1,2, Giuseppina...

Cimeio Therapeutics Announces Publication of Seminal Epitope Editing Work in the Journal of Experimental Medicine

by admin | Sep 29, 2023 | Press Release

Cimeio Therapeutics Announces Publication of Seminal Epitope Editing Work in the Journal of Experimental Medicine — Research demonstrates that engineering the epitope of the cell surface protein CD123 in hematopoietic stem cells protects them from targeted...

Recent Posts

  • Cimeio Therapeutics Announces Partnership with Kyowa Kirin to Develop Novel Cell Therapies
  • Cimeio Therapeutics Therapy Platform Featured in Forbes Article
  • Selective haematological cancer eradication with preserved haematopoiesis
  • Cimeio Therapeutics Announces Publication in Nature Demonstrating That CD45 ADC and Shielded HSCs Represent a Potentially Universal Therapy for Blood Cancers
  • Molecular shielding of CD52 retains expression, anti-phagocytic ‘don’t eat me’ function and protects from Alemtuzumab-mediated depletion

Recent Comments

No comments to show.
Cimeio Therapeutics Logo

Transforming Hematopoietic Stem Cell Transplant and Adoptive Cell Therapies


Cimeio Therapeutics, Inc.
1 Broadway, 14th floor
Cambridge, MA 02142
USA


+41 61 225 46 00

Sitemap

  • Home
  • About Us
  • Publications
  • News
  • Contact Us
  • Careers

© 2022-2023 Cimeio Therapeutics, Inc.

  • Follow
Contact Us
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}